azoxymethane has been researched along with tretinoin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alousi, MA; Bull, AW; Nigro, ND; Soullier, BK; Wilson, PS | 1 |
| Bird, RP; Stopera, SA | 1 |
| Kelloff, GJ; Kramer, PM; Lubet, RA; Olson, G; Pereira, MA; Steele, VE; Zheng, Y | 1 |
| Kelloff, GJ; Kramer, PM; Lubet, RA; Pereira, MA; Steele, VE; Zheng, Y | 1 |
| Baba, M; Iishi, H; Ishiguro, S; Narahara, H; Sakai, N; Tatsuta, M; Uedo, N; Yano, H | 1 |
5 other study(ies) available for azoxymethane and tretinoin
| Article | Year |
|---|---|
Combined inhibitors of carcinogenesis: effect on azoxymethane-induced intestinal cancer in rats.
Topics: Animals; Azo Compounds; Azoxymethane; Body Weight; Drinking; Eating; Intestinal Neoplasms; Male; Rats; Rats, Inbred Strains; Selenium; Sitosterols; Tretinoin | 1982 |
Effects of all-trans retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci: differential expression of c-myc and c-fos MRNA and protein.
Topics: Animals; Azoxymethane; Body Weight; Colon; Colonic Neoplasms; Genes, fos; Genes, myc; Male; Precancerous Conditions; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tretinoin | 1993 |
Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats.
Topics: Alitretinoin; Animals; Anticarcinogenic Agents; Azoxymethane; Cell Division; Colonic Neoplasms; Fenretinide; Male; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred F344; Tretinoin | 1997 |
Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci.
Topics: Adenocarcinoma; Adenoma; Animals; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Body Weight; Carcinogens; Colon; Colonic Neoplasms; Drug Screening Assays, Antitumor; Fenretinide; Male; Precancerous Conditions; Rats; Rats, Inbred F344; Tretinoin | 1999 |
K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Azoxymethane; Base Sequence; Carcinogens; Colon; Colonic Neoplasms; Deoxycholic Acid; Drug Synergism; Genes, ras; Intestinal Mucosa; Male; Mitotic Index; Point Mutation; Proto-Oncogene Proteins p21(ras); Rats; Rats, Wistar; Tretinoin | 2000 |